PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Guidelines : Constipation
Guidelines : Constipation
Additional Documents
Type
Document
Review Date
Other Drugs
- Macrogol 3350
- Methylnaltrexone bromide
- Prucalopride
- Naloxegol
- Ispaghula husk
- Bisacodyl
- Docusate sodium
- Glycerol
- Senna
- Lactulose
- Phosphates (Rectal)
- Sterculia
- Co-danthrusate (Dantron/docusate sodium)
- Co-danthramer (Dantron/poloxamer 188)
- Sodium citrate (Rectal)
- Naldemedine
- Arachis oil
- Magnesium hydroxide
- Sodium picosulfate
Committee Recommendations
Date
Committee Name
Narrative
03 July 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands APC have adopted the CKS principles for the management of constipation in adults.
The CKS guidance includes the management of constipation in adults (including pregnant women and those who are breastfeeding), for short-duration and chronic constipation, and faecal loading and/or impaction.
Refer to the formulary Traffic Light Status / place in therapy advice for locally agreed treatment options.
02 December 2020
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Integrated Care System Area Prescribing Committee have reviewed and approved the updated prescribing guidance for the treatment of constipation in adults in primary care - see guidance document below
01 March 2017
NW Surrey Medicines Optimisation Group
NW Surrey CCG and ASPH Trust have agreed this local resource to aid service improvement in care homes.